Seeing Is Believing
ACAD is currently covered by 25 analysts with an average price target of $27.04. This is a potential upside of $7.09 (35.54%) from yesterday's end of day stock price of $19.95.
ACADIA Pharmaceuticals's activity chart (see below) currently has 310 price targets and 304 ratings on display. The stock rating distribution of ACAD is 35.85% HOLD, 63.21% BUY and 0.94% SELL.
Analysts average stock forecasts to be materialized ratio is 63.71% with an average time for these price targets to be met of 202.23 days.
Highest price target for ACAD is $37, Lowest price target is $19, average price target is $27.04.
Most recent stock forecast was given by NEENA BITRITTO-GARG from on 11-Feb-2025. First documented stock forecast 06-May-2013.
Currently out of the existing stock ratings of ACAD, 38 are a HOLD (35.85%), 67 are a BUY (63.21%), 1 are a SELL (0.94%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$22
$2.05 (10.28%)
$24
11 days ago
(11-Feb-2025)
16/21 (76.19%)
$3.51 (18.98%)
174
Hold
$20
$0.05 (0.25%)
$25
1 months 19 days ago
(03-Jan-2025)
5/6 (83.33%)
$1.59 (8.64%)
172
Buy
$27
$7.05 (35.34%)
$27
3 months 15 days ago
(07-Nov-2024)
7/20 (35%)
$9.8 (56.98%)
118
Buy
$28
$8.05 (40.35%)
$28
3 months 15 days ago
(07-Nov-2024)
0/5 (0%)
$10.8 (62.79%)
Hold
4 months 12 days ago
(10-Oct-2024)
11/14 (78.57%)
$9.98 (39.89%)
141
What is ACAD (ACADIA Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ACAD (ACADIA Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ACAD (ACADIA Pharmaceuticals)?
Which analyst is the currently most bullish on ACAD (ACADIA Pharmaceuticals)?
Which analyst is the currently most reserved on ACAD (ACADIA Pharmaceuticals)?